C07D 455/06
Containing benzo [a] quinolizine ring systems
Official title: containing benzo [a] quinolizine ring systems
C07D455/06 (Containing benzo [a] quinolizine ring systems) appears on 111 US grants and 143 published applications in this corpus.
Search patents in C07D- Granted patents
- 111
- Published applications
- 143
- Assignees
- 56
- Inventors
- 291
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 3 | 0 |
| 1979 | 1 | 0 |
| 1980 | 6 | 0 |
| 1981 | 0 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 3 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 4 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 2 |
| 2003 | 0 | 1 |
| 2004 | 2 | 3 |
| 2005 | 4 | 2 |
| 2006 | 0 | 2 |
| 2007 | 1 | 1 |
| 2008 | 0 | 6 |
| 2009 | 0 | 5 |
| 2010 | 2 | 5 |
| 2011 | 8 | 2 |
| 2012 | 1 | 3 |
| 2013 | 3 | 6 |
| 2014 | 1 | 8 |
| 2015 | 1 | 9 |
| 2016 | 6 | 10 |
| 2017 | 1 | 8 |
| 2018 | 3 | 6 |
| 2019 | 6 | 12 |
| 2020 | 7 | 22 |
| 2021 | 8 | 11 |
| 2022 | 7 | 7 |
| 2023 | 6 | 2 |
| 2024 | 1 | 4 |
| 2025 | 1 | 4 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Processes for the preparation of multicomponent crystalline forms of active pharmaceutical ingredients using solvent vapour24 Mar 2026US 12,583,860 B2Apotex Inc.
- VMAT2 inhibitor and preparation method therefor and application thereof3 Mar 2026US 12,565,495 B2Luye Innomind Pharma Shijiazhuang Co., Ltd.
- Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid26 Aug 2025US 12,398,169 B2H. Lundbeck A.S.
- Methods of manufacturing benzoquinoline compounds3 Sep 2024US 12,077,487 B2Auspex Pharmaceuticals, Inc.
- Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid26 Dec 2023US 11,851,456 B2H. Lundbeck A.S.
- Vmat2 inhibitor and preparation method therefor and application thereof2 Apr 2026US 2026/0091029 A1Luye Innomind Pharma Shijiazhuang Co., Ltd.
- Methods for the administration of certain vmat2 inhibitors19 Feb 2026US 2026/0048042 A1Neurocrine Biosciences, Inc.
- Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 223 Oct 2025US 2025/0326747 A1Auspex Pharmaceuticals, Inc.
- Novel hepatoselective polyadenylating polymerases inhibitors and their method of use25 Sep 2025US 2025/0296929 A1Baruch S. Blumberg Institute
- Fused ring compound11 Sep 2025US 2025/0282774 A1Shanghai Shijiang Biotechnology Co., Ltd
Most cited
By later US patents
- Pyrido[2,1-A]Isoquinoline derivatives112US 6,727,261 B2Hoffman-La Roche Inc. · 2004
- Benzoquinoline inhibitors of vesicular monoamine transporter 247US 8,524,733 B2Auspex Pharmaceuticals, Inc. · 2013
- Glucocorticoid receptor modulators32US 6,380,223 B1Pfizer Inc. · 2002
- Amino-esters of dihydropyridines useful for improving circulation in patients30US 5,063,239 ABayer Aktiengesellschaft · 1991
- Treating gastro-intestinal disorders and emesis with n-(heterocyclic substituted) benzamides29US 4,213,983 ABeecham Group Limited · 1980